Medical Diagnostic and Treatment Center
| リトアニア | トルコ | オーストリア | |
| 小線源治療 | - | から $3,465 | から $15,000 |
| 子宮頸部摘出術 | - | から $2,500 | から $15,000 |
| 子宮頸部摘出術 | - | から $5,500 | から $14,500 |
| 子宮頸部円錐切除術 | - | から $1,200 | から $2,800 |
| 子宮頸癌の放射線療法 | - | から $4,000 | から $15,000 |
Bookimedは子宮頸癌治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。子宮頸癌治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。子宮頸癌治療の旅路でお一人になることはありません。
Cervical cancer treatment in Lithuania follows European protocols, prioritizing surgery, radiotherapy, and chemo-immunotherapy. Early-stage patients often receive fertility-sparing trachelectomy or hysterectomy. Advanced cases typically transition to concurrent chemoradiation. Facilities like the Medical Diagnostic and Treatment Center in Vilnius maintain JCI and Temos accreditations.
Bookimed Expert Insight: While the public healthcare system is well-equipped, wait times often reach two months. Private clinics like the Medical Diagnostic and Treatment Center serve 60,000 patients annually. They provide a vital alternative for international patients seeking faster surgical access. These facilities often mirror German equipment standards through extensive EU-funded upgrades.
Patient Consensus: Patients mention that starting private care can significantly speed up the process. They also suggest confirming HPV status early to unlock specific targeted therapy options.
Lithuania specializes in cervical cancer care through a network of state university hospitals and JCI-accredited facilities. Key centers include the National Cancer Institute (NVI) and Medical Diagnostic and Treatment Center in Vilnius. These facilities provide advanced diagnostics, brachytherapy, and robotic-assisted surgeries for oncogynecology patients.
Bookimed Expert Insight: Data shows that Medical Diagnostic and Treatment Center serves many international patients. Approximately 10% of their 60,000 annual patients travel from the UK and Scandinavia. This reflects a high trust in Lithuanian private diagnostics for rapid cancer staging. Short wait times for scans here complement the specialized surgical expertise found in public centers.
Patient Consensus: Patients note that private clinics offer diagnostics within days while public hospitals are the primary choice for complex surgeries. Many recommend getting HPV genotyping early and checking local support groups for specific surgeon feedback.
Lithuania reports an overall 5-year survival rate of approximately 56% for cervical cancer. Early diagnosis remains critical for success. Patients diagnosed at Stage I reach a 90% survival rate. Advanced cases show significantly lower outcomes compared to the European Union average of 66.6%.
Bookimed Expert Insight: Quality indicators at the Medical Diagnostic and Treatment Center suggest a strong international preference. One in 10 patients travels from high-standard regions like the UK or Norway. This clinic manages 60,000 yearly visits across 53 specialized departments. Our data shows that modern JCI-accredited infrastructure helps bridge the survival gap. These facilities prioritize rapid staging to prevent the 3-month delays seen in public systems.
Patient Consensus: Patients emphasize that early stage survival often exceeds 90% when treated immediately. Many suggest seeking private diagnostics to avoid long wait times that could let the cancer progress.
Lithuania's national screening program provides free cervical cancer checks for women aged 25 to 60. The program typically uses a Pap smear every 3 years to detect abnormal changes. Compulsory health insurance covers these services. Family doctors usually initiate the process during routine visits.
Bookimed Expert Insight: While the national program is robust, patient volume at major centers like the Medical Diagnostic and Treatment Center in Vilnius reaches 60,000 patients annually. This high volume suggests that urban facilities are deeply integrated with the e-health system. Patients can often track their screening invitations and results through the e-sveikata portal for faster follow-up coordination.
Patient Consensus: Patients suggest using the e-sveikata portal to check for invitations since busy doctors might miss follow-ups. Many note that while public screening is free, some prefer paying for private tests to avoid potential 3-week waits for results.
Lithuanian oncology centers offer minimally invasive cervical cancer treatments including robotic hysterectomies and cone biopsies. Fertility-preserving options like trachelectomy are available for early-stage cases. Facilities like the Medical Diagnostic and Treatment Center in Vilnius maintain JCI accreditation, ensuring high-quality surgical safety and patient care standards.
Bookimed Expert Insight: While robotic options exist, they are often concentrated in major Vilnius centers. The Medical Diagnostic and Treatment Center stands out because 10% of its patients are international. This suggests a high level of comfort with complex cases that require modernized, minimally invasive approaches over traditional open surgery.
Patient Consensus: Patients note it is important to ask about a surgeon's specific experience with fertility-sparing techniques. Many emphasize seeking second opinions if a radical hysterectomy is the only option initially presented.
Targeted therapy for recurrent cervical cancer is accessible in Lithuania following specialized biomarker testing. Access depends on identifying specific genetic proteins like PD-L1 or MSI-high status. While standard combinations are available, novel agents often require clinical trials or compassionate use programs.
Bookimed Expert Insight: Genetic screening is the most critical step for recurrent cases in Lithuania. Our data shows the Medical Diagnostic and Treatment Center focuses heavily on accurate diagnostics with 200 doctors. This specialty is vital because specific mutations determine if expensive targeted cycles are effective. Patients often use these precise results to qualify for international clinical trials when local options are limited.
Patient Consensus: Patients note that while the public system covers basic treatments, novel targeted drugs may require crowdfunding. Many emphasize getting genomic testing early to avoid a six-month wait for therapy approvals.
Quality oncologic care is ensured through international accreditations like JCI and Temos. These bodies validate surgical safety, clinical protocols, and patient outcomes. Specialist-led care and multidisciplinary tumor boards further guarantee evidence-based treatment for complex cases like cervical cancer.
Bookimed Expert Insight: Quality signals in Lithuania often hide in the patient demographics. At the Medical Diagnostic and Treatment Center in Vilnius, 1 in 10 patients is an international traveler. This high volume of foreign patients suggests the facility meets strict European service standards beyond local requirements.
Patient Consensus: Patients note that finding a dedicated gynecologic oncologist is more important than a general surgeon. They emphasize that experienced centers are more transparent about their specific procedure success rates.